Search Results

There are 3287 results for: content related to: Systematic review of levodopa dose equivalency reporting in Parkinson's disease

  1. POLG, but not PEO1, is a frequent cause of cerebellar ataxia in Central Europe

    Movement Disorders

    Volume 25, Issue 15, 15 November 2010, Pages: 2678–2682, Julia Schicks, Matthis Synofzik, Claudia Schulte and Ludger Schöls

    Version of Record online : 27 AUG 2010, DOI: 10.1002/mds.23286

  2. Development of a physiologically based pharmacokinetic/pharmacodynamic model to identify mechanisms contributing to entacapone low bioavailability

    Biopharmaceutics & Drug Disposition

    Volume 36, Issue 9, December 2015, Pages: 587–602, Saeed Alqahtani and Amal Kaddoumi

    Version of Record online : 24 DEC 2015, DOI: 10.1002/bdd.1986

  3. Entacapone enhances levodopa-induced reversal of motor disability in MPTP-treated common marmosets

    Movement Disorders

    Volume 12, Issue 6, November 1997, Pages: 935–945, Lance A. Smith, Ariel Gordin, Dr. Peter Jenner and C. David Marsden

    Version of Record online : 4 NOV 2004, DOI: 10.1002/mds.870120616

  4. Distinct basal ganglia hyperechogenicity in idiopathic basal ganglia calcification

    Movement Disorders

    Volume 25, Issue 15, 15 November 2010, Pages: 2661–2664, Norbert Brüggemann, Susanne A. Schneider, Thurid Sander, Christine Klein and Johann Hagenah

    Version of Record online : 27 AUG 2010, DOI: 10.1002/mds.23264

  5. Advanced magnetic resonance imaging in benign hereditary chorea: Study of two familial cases

    Movement Disorders

    Volume 25, Issue 15, 15 November 2010, Pages: 2670–2674, Gloria Maccabelli, Anna Pichiecchio, Andrea Guala, Michela Ponzio, Fulvia Palesi, Diego Maranzana, RT, Guy Umberto Poloni, Stefano Bastianello and Cesare Danesino

    Version of Record online : 27 AUG 2010, DOI: 10.1002/mds.23281

  6. Restless legs syndrome and Parkinson's disease in men

    Movement Disorders

    Volume 25, Issue 15, 15 November 2010, Pages: 2654–2657, Xiang Gao, Michael A. Schwarzschild, Eilis J. O'Reilly, Hao Wang and Alberto Ascherio

    Version of Record online : 24 AUG 2010, DOI: 10.1002/mds.23256

  7. Entacapone in combination with standard or controlled-release levodopa/carbidopa: a clinical and pharmacokinetic study in patients with Parkinson's disease

    European Journal of Neurology

    Volume 2, Issue 4, September 1995, Pages: 341–347, S. Kaakkola, H. Teräväinen, S. Ahtila, M. Karlsson, T. Naukkarinen, H. Rita and A. Gordin

    Version of Record online : 20 JAN 2011, DOI: 10.1111/j.1468-1331.1995.tb00137.x

  8. You have free access to this content
    Entacapone improves the availability of l-dopa in plasma by decreasing its peripheral metabolism independent of l-dopa/carbidopa dose

    British Journal of Clinical Pharmacology

    Volume 54, Issue 4, October 2002, Pages: 363–371, Helena Heikkinen, Anu Varhe, Tarmo Laine, Jaakko Puttonen, Marjo Kela, Seppo Kaakkola and Kari Reinikainen

    Version of Record online : 23 OCT 2002, DOI: 10.1046/j.1365-2125.2002.01654.x

  9. Delayed administration may improve entacapone effects in parkinsonian patients non-responding to the drug

    European Journal of Neurology

    Volume 11, Issue 9, September 2004, Pages: 593–606, L. Brusa, A. Bassi, G. Lunardi, E. Fedele, A. Peppe, A. Stefani, P. Pasqualetti, P. Stanzione and M. Pierantozzi

    Version of Record online : 15 SEP 2004, DOI: 10.1111/j.1468-1331.2004.00860.x

  10. What is the functional significance of nondominant arm tremor in essential tremor?

    Movement Disorders

    Volume 25, Issue 15, 15 November 2010, Pages: 2674–2678, Elan D. Louis, Marina Gerbin and Mary M. Mullaney

    Version of Record online : 27 AUG 2010, DOI: 10.1002/mds.23284

  11. Pooled analysis of phase III with entacapone in Parkinson's disease

    Acta Neurologica Scandinavica

    Volume 130, Issue 4, October 2014, Pages: 239–247, M. Kuoppamäki, M. Vahteristo, J. Ellmén and K. Kieburtz

    Version of Record online : 3 SEP 2014, DOI: 10.1111/ane.12278

  12. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  13. You have free access to this content
    Pharmacodynamic Response of Entacapone in Rats after Administration of Entacapone Formulations and Prodrugs with Varying Bioavailabilities

    Pharmacology & Toxicology

    Volume 90, Issue 6, June 2002, Pages: 327–332, Markus Forsberg, Jouko Savolainen, Tomi Järvinen, Jukka Leppänen, Jukka Gynther and Pekka T. Männistö

    Version of Record online : 1 JUL 2002, DOI: 10.1034/j.1600-0773.2002.900606.x

  14. Twelve-month safety of entacapone in patients with Parkinson’s disease

    European Journal of Neurology

    Volume 8, Issue 1, January 2001, Pages: 53–60, V. V. Myllylä, E.-R. Kultalahti, H. Haapaniemi, M. Leinonen and FILOMEN Study Group

    Version of Record online : 21 DEC 2001, DOI: 10.1046/j.1468-1331.2001.00168.x

  15. Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal Levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study)

    Acta Neurologica Scandinavica

    Volume 105, Issue 4, April 2002, Pages: 245–255, W. H. Poewe, G. Deuschl, A. Gordin, E.-R. Kultalahti, M. Leinonen and the Celomen Study Group

    Version of Record online : 3 APR 2002, DOI: 10.1034/j.1600-0404.2002.1o174.x

  16. Effects of aqueous solubility and dissolution characteristics on oral bioavailability of entacapone

    Drug Development Research

    Volume 49, Issue 4, April 2000, Pages: 238–244, Jouko Savolainen, Markus Forsberg, Hannu Taipale, Pekka T. Männistö, Kristiina Järvinen, Jukka Gynther, Pekka Jarho and Tomi Järvinen

    Version of Record online : 12 JUN 2000, DOI: 10.1002/1098-2299(200004)49:4<238::AID-DDR2>3.0.CO;2-V

  17. Restless legs syndrome in patients with amyotrophic lateral sclerosis

    Movement Disorders

    Volume 25, Issue 15, 15 November 2010, Pages: 2658–2661, Daniele Lo Coco, Federico Piccoli and Vincenzo La Bella

    Version of Record online : 10 NOV 2010, DOI: 10.1002/mds.23261

  18. Impaired sense of smell and color discrimination in monogenic and idiopathic Parkinson's disease

    Movement Disorders

    Volume 25, Issue 15, 15 November 2010, Pages: 2665–2669, Lena Kertelge, Norbert Brüggemann, Alexander Schmidt, Vera Tadic, Claudia Wisse, Sylwia Dankert, Laura Drude, Joyce van der Vegt, Hartwig Siebner, Heike Pawlack, Peter P. Pramstaller, Maria Isabel Behrens, Alfredo Ramirez, Dirk Reichel, Carsten Buhmann, Johann Hagenah, Christine Klein, Katja Lohmann and Meike Kasten

    Version of Record online : 18 AUG 2010, DOI: 10.1002/mds.23272

  19. CSF Aβ42 and tau in Parkinson's disease with cognitive impairment

    Movement Disorders

    Volume 25, Issue 15, 15 November 2010, Pages: 2682–2685, Thomas J. Montine, Min Shi, Joseph F. Quinn, Elaine R. Peskind, Suzanne Craft, Carmen Ginghina, Kathryn A. Chung, Hojoong Kim, Douglas R. Galasko, Joseph Jankovic, Cyrus P. Zabetian, James B. Leverenz and Jing Zhang

    Version of Record online : 3 SEP 2010, DOI: 10.1002/mds.23287

  20. You have free access to this content
    Evidence-Based Efficacy Comparison of Tolcapone and Entacapone as Adjunctive Therapy in Parkinson's Disease

    CNS Neuroscience & Therapeutics

    Volume 14, Issue 1, Spring 2008, Pages: 83–93, Andrew J. Lees

    Version of Record online : 14 MAR 2008, DOI: 10.1111/j.1527-3458.2007.00035.x